Stone House Investment Management, LLC
Position in TGTX — Tg Therapeutics, Inc.
CIK 1696497
TUNKHANNOCK, PA
Position in TGTX
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$33,220
+$3,321 QoQ
Shares Held
1,000
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Stone House Investment Management, LLC holds $360,244 across 50 Biotechnology names. TGTX ranks #4 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AUPH |
Aurinia Pharmaceuticals Inc.
|
6,620 | $98,108 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
1,002 | $49,148 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
83 | $37,062 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
This page
|
1,000 | $33,220 | |
| 5 | INSM |
INSMED Inc
|
200 | $32,704 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
800 | $26,032 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
1,000 | $18,900 | |
| 8 | STOK |
Stoke Therapeutics, Inc.
|
500 | $16,280 |
All Filings in TGTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,220 | 1,000 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $29,899 | 1,003 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $36,233 | 1,003 | Shares | Sole | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||